Cost of cardiovascular disease in US shows marked risePharmacoEconomics & Outcomes News -doi:10.1007/BF03269858NoneSpringer International PublishingPharmacoEconomics & Outcomes News Weekly
Cost-effectiveness analysis of interventions to prevent cardiovascular disease in Vietnam Vietnam is in the process of an epidemiological transition, with cardiovascular disease (CVD) now ranked as the leading cause of death. The burden of CVD w... HD Anh,C Dan - 《Health Policy & Planning》...
An understanding of preventative strategies and therapies for CV risk factors and CV disease has improved; however, it is important to determine secular trends in CV risk factor and disease development to project future needs for prevention and treatment efforts and to identify higher risk subgroups ...
Almost 80% of the global burden of cardiovascular disease (CVD) occurs in low- and middle-income countries (LMICs). However, LMICs do not have well-established, low-technology ways to quantify and communicate CVD risk at population or individual levels. We examined predicted heart/vascular age ...
Cardiovascular disease (CVD) is an emerging contributor to national morbidity and mortality in Saudi Arabia. CVD risk prevention services are limited, particularly with an over-utilised public health sector and an under-utilised and under-resourced prima
Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart. 2002;88(2):119-124. doi:10.1136/heart.88.2.119 PubMedGoogle Scholar 16. Lopez AD, Adair T. Is the long-term decline in cardiovascular-disease mortality in ...
In GBD 2019, a Bayesian meta-regression disease modeling tool (i.e., DisMod-MR-2.1) was used to estimate the incidence and prevalence of overall and type-specific CVDs produced by population surveys, cohorts and registries, health system administrative data, and microdata from registry and ...
OBJECTIVE: To evaluate the public health and economic benefits of adherence to a fixed-dose combination polypill for the secondary prevention of cardiovascular (CV) events in adults with a history of myocardial infarction (MI) in the UK. DESIGN: Markov-model-based cost-effectiveness analysis, infor...
Cardiovascular diseases (CVDs) are the leading cause of death and a major cause of disability and loss of productivity in adults world wide [1]. The annual cost of CVD is estimated to be €169 billion a year in the enlarged European Union and $394 billion (€296) in the USA [2, 3]...
While increased fitness protects against cardiovascular disease [21], the cost-effectiveness of wellness/fitness programs versus real-time physiologic monitors for CVE prevention on the fire-ground is uncertain. With this in mind, we performed a cost-effectiveness analysis, not to find a definitive ...